Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Chubb
Daiichi Sankyo
McKinsey
UBS
Johnson and Johnson
Queensland Health
Chinese Patent Office
Merck
Fish and Richardson

Generated: February 25, 2018

DrugPatentWatch Database Preview

NAPROXEN Drug Profile

« Back to Dashboard

Which patents cover Naproxen, and when can generic versions of Naproxen launch?

Naproxen is a drug marketed by West-ward Pharms Int, Actavis Elizabeth, Fosun Pharma, Invagen Pharms, Mylan Pharms Inc, Pliva, Teva, Amneal Pharms Ny, Aurobindo Pharma Ltd, Chartwell Molecules, Dava Pharms Inc, Glenmark Generics, Hamilton Pharms, Hikma Intl Pharms, Ivax Sub Teva Pharms, Marksans Pharma, Mylan, Perrigo R And D, Purepac Pharm, Roxane, Teva Pharms, Watson Labs, Watson Labs Teva, Zydus Pharms Usa, Dr Reddys Labs Ltd, Bionpharma Inc, Actavis Labs Fl Inc, Able, Contract Pharmacal, Dr Reddys Labs Inc, Glenmark Pharms Ltd, Granules India, Hikma, Lnk Intl Inc, Perrigo, Sandoz, and Sun Pharm Inds Ltd. and is included in sixty-four NDAs. There are two patents protecting this drug and one Paragraph IV challenge.

The generic ingredient in NAPROXEN is naproxen sodium; pseudoephedrine hydrochloride. There are forty-two drug master file entries for this compound. Twelve suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the naproxen sodium; pseudoephedrine hydrochloride profile page.

US Patents and Regulatory Information for NAPROXEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms NAPROXEN naproxen TABLET;ORAL 074207-002 Dec 21, 1993 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Dr Reddys Labs Ltd NAPROXEN SODIUM naproxen sodium TABLET;ORAL 078486-001 Jul 26, 2007 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ivax Sub Teva Pharms NAPROXEN naproxen TABLET;ORAL 074111-001 Feb 28, 1995 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hamilton Pharms NAPROXEN naproxen TABLET;ORAL 074110-001 Oct 30, 1992 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bionpharma Inc NAPROXEN SODIUM naproxen sodium CAPSULE;ORAL 021920-001 Feb 17, 2006 OTC Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Mylan NAPROXEN SODIUM naproxen sodium TABLET;ORAL 074367-001 Aug 31, 1994 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan NAPROXEN naproxen TABLET;ORAL 074121-003 Dec 21, 1993 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ivax Sub Teva Pharms NAPROXEN SODIUM naproxen sodium TABLET;ORAL 074230-002 Mar 14, 1995 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Roxane NAPROXEN naproxen TABLET;ORAL 074211-002 Feb 28, 1994 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Marksans Pharma NAPROXEN naproxen TABLET;ORAL 091416-002 Feb 14, 2011 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for NAPROXEN
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Capsules 200 mg ➤ Subscribe 11/15/2017

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
US Department of Justice
Deloitte
Farmers Insurance
UBS
Julphar
Baxter
Chinese Patent Office
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot